Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-01-04
1994-10-18
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530383, 424530, A61K 3514, C07K 1300, C07K 320
Patent
active
053568788
ABSTRACT:
Highly purified antihemophilic factor is produced by a process comprising a PEG precipitation step, a gel filtration step and a virus inactivation step. Al(OH).sub.3 adsorption and PEG precipitation carried out at room temperature allow processing to proceed directly to a gel filtration step.
REFERENCES:
patent: 4020713 (1977-05-01), Bick et al.
patent: 4670543 (1987-06-01), Bourgois et al.
patent: 4774323 (1988-09-01), Newman et al.
Thorell et al. "An In Vivo Study of a New Factor VIII Layer Purity Preparation", Thromb. Res vol. 31, pp. 375-385 (1983).
Brockway William J.
Seng Richard L.
Bradley Bertram
Giblin James A.
Miles Inc.
Schain Howard E.
Touzeau P. Lynn
LandOfFree
Gel filtration of factor VIII does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gel filtration of factor VIII, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gel filtration of factor VIII will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2372477